Literature DB >> 1783993

Disposition of prednisone and prednisolone in the perfused rabbit liver: modeling hepatic metabolic processes.

V G Hale1, K Aizawa, L B Sheiner, L Z Benet.   

Abstract

The livers of 15 rabbits were perfused in situ with prednisone (PO) or prednisolone (POH) over a wide range of steady state concentrations, resulting in multiple experimental measurements per organ. Linearity of extraction, an apparent lack of oxidative conversion, and marked preference for the reduction of PO to POH was observed. Predictions of hepatic tissue concentrations were made using both the well-stirred and parallel-tube model approximations. Glucocorticoid disposition across the liver was described by a series of differential equations. Discrimination between the two models was accomplished by examining the effects of changes in flow rate upon the availability of the highly extracted drug PO. The well-stirred model very closely predicted the observed changes in availability of PO, whereas the parallel-tube model provided poor predictions. The intrinsic clearances of interconversion and elimination of PO and POH were subsequently calculated by population analysis using NONMEM. This method assumed the well-stirred model and resulted in intrinsic clearance estimates of 26 ml/min for the elimination of POH, 157 ml/min for reductive conversion of PO to POH, and 205 ml/min for the irreversible elimination of PO. A mechanism of intrahepatic disposition of these glucocorticoids was proposed using well-stirred model predictions of hepatic drug concentrations, the perfusion rate limitation to drug transport, and the assumption of no oxidative interconversion of POH to PO. In this case, the capacity for reduction of PO to POH approaches the elimination clearance of PO and the elimination of PO is about 13 times greater than the elimination clearance of POH.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1783993     DOI: 10.1007/bf01062965

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  24 in total

1.  Liver circulation and function.

Authors:  R W BRAUER
Journal:  Physiol Rev       Date:  1963-01       Impact factor: 37.312

2.  Dose-dependent pharmacokinetics of prednisone and prednisolone in man.

Authors:  J C Loo; I J McGilveray; N Jordan; J Moffat; R Brien
Journal:  J Pharm Pharmacol       Date:  1978-11       Impact factor: 3.765

3.  A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations.

Authors:  M S Roberts; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1986-06

4.  Metabolism and conjugation of cortisol by various dog tissues in vitro.

Authors:  S Miyabo; S Kishida; T Hisada
Journal:  J Steroid Biochem       Date:  1973-11       Impact factor: 4.292

5.  Models of hepatic drug clearance: discrimination between the 'well stirred' and 'parallel-tube' models.

Authors:  A B Ahmad; P N Bennett; M Rowland
Journal:  J Pharm Pharmacol       Date:  1983-04       Impact factor: 3.765

6.  Ontogeny of cortisol-cortisone interconversion in human tissues: a role for cortisone in human fetal development.

Authors:  B E Murphy
Journal:  J Steroid Biochem       Date:  1981-09       Impact factor: 4.292

7.  Steroid-protein interaction: substrate specificity of 20 beta-hydroxysteroid dehydrogenase.

Authors:  J Kawamura; T Hayakawa; T Tanimoto
Journal:  Chem Pharm Bull (Tokyo)       Date:  1980-02       Impact factor: 1.645

8.  Cortisol:cortisone interconversion by human decidua in relation to parturition: effect of tissue manipulation on 11 beta-hydroxysteroid dehydrogenase activity.

Authors:  A López Bernal; A B Anderson; A C Turnbull
Journal:  J Endocrinol       Date:  1982-05       Impact factor: 4.286

9.  The macromolecular binding of prednisone in plasma of healthy volunteers including pregnant women and oral contraceptive users.

Authors:  L E Gustavson; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1985-12

10.  Prednisolone clearance at steady state in man.

Authors:  U F Legler; F J Frey; L Z Benet
Journal:  J Clin Endocrinol Metab       Date:  1982-10       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.